p. 13213 - 13216
(2015)p. 72579 - 72589
(2015)p. 7736 - 7749
(2015)p. 989 - 1000
(2018/01/01)p. 3013 - 3024
(2017/04/10)(2017/09/02)
p. 1181 - 1189
(2016/08/11)p. 11125 - 11136
(2016/12/07)(2015/07/07)
p. 823 - 831
(2014/01/23)p. 551 - 558
(2013/07/27)p. 16256 - 16262
(2013/12/04)(2011/10/04)
p. 7841 - 7852
(2010/11/16)p. 5967 - 5979
(2011/02/26)p. 9717 - 9724
(2008/12/22)p. 6885 - 6888
(2009/04/07)p. 9493 - 9501
(2008/02/11)p. 853 - 859
(2007/10/03)p. 2802 - 2804
(2007/10/03)p. 3879 - 3890
(2007/10/03)p. 6677 - 6686
(2007/10/03)p. 1661 - 1664
(2007/10/03)p. 738 - 739
(2007/10/03)p. 3489 - 3494
(2007/10/03)p. 3343 - 3346
(2007/10/03)p. 2841 - 2845
(2007/10/02)p. 1 - 10
(2007/10/02)p. 689 - 691
(2007/10/02)p. 4451 - 4454
(2007/10/02)1-hydroxy-pyrrolidine-2,5-dione
(S)-N-(benzyloxycarbonyl)valine
N,N’-disuccinimidyl oxalate
Isopropenyl Succinimido Carbonate
benzyl chloroformate
N,N'-bis(N-Cbz-L-valinyl)-1,2-diaminoethane
N-[(Benzyloxy)carbonyl]-L-valyl-N5-carbamoyl-L-ornithine
(S)-6-Allyloxycarbonylamino-2-((S)-2-benzyloxycarbonylamino-3-methyl-butyrylamino)-hexanoic acid
N-benzyloxycarbonyl-L-valyl-L-proline
N-benzyloxycarbonyl-L-valinol